Celanese Corp.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: US1508701034
USD
39.84
-2 (-4.78%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Celanese Corp. stock-summary
stock-summary
Celanese Corp.
Specialty Chemicals
Celanese Corporation (Celanese) is a technology and specialty materials company. The Company's segments include Advanced Engineered Materials, Consumer Specialties, Industrial Specialties, Acetyl Intermediates and Other Activities. The Advanced Engineered Materials segment includes the Company's engineered materials business and certain affiliates. The Consumer Specialties segment includes the Company's cellulose derivatives and food ingredients businesses, which serve consumer-driven applications. The Industrial Specialties segment includes the Company's emulsion polymers and ethylene vinyl acetate (EVA) polymers businesses. The Acetyl Intermediates segment includes the Company's intermediate chemistry business, which produces and supplies acetyl products, including acetic acid, vinyl acetate monomer (VAM), acetic anhydride and acetate esters. The Company has operations in North America, Europe and Asia. As of December 31, 2016, the Company had 30 global production facilities.
Company Coordinates stock-summary
Company Details
222 Las Colinas Blvd W Ste 900N , IRVING TX : 75039-5467
stock-summary
Tel: 1 972 44340001 972 4433728
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 118 Schemes (86.41%)

Foreign Institutions

Held by 296 Foreign Institutions (19.69%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Ms. Lori Ryerkerk
Chairman of the Board, President, Chief Executive Officer
Mr. Edward Galante
Lead Independent Director
Ms. Deborah Kissire
Director
Ms. Jean Blackwell
Independent Director
Mr. William Brown
Independent Director
Ms. Kathryn Hill
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
2,532 Million
(Quarterly Results - Jun 2025)
Net Profit:
212 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 7,910 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.09%

stock-summary
Debt Equity

2.25

stock-summary
Return on Equity

1.04%

stock-summary
Price to Book

1.50